Thursday, November 19, 2015 8:22:58 PM
They loss some value in their IP but oddly saving up more cash. Not much but still much higher than most OTC stock which had negative balance.
They even mentioned they have reviewed several merger partners. That might explain the A/S increase beside one new Note they recently gave out in September which shouldn't require 2.3Billion increase. Their old A/S would have cover that with a bunch of shares left over.
-----------------------
Do not trust CEO/PR, it's time to sell and move on. CEO will still be there. This is not NYSE
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM